TTK Healthcare Limited has informed the Exchange regarding Appointment of as Other of the company w.e.f. May 30, 2026.
TTKHLTCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
TTK Healthcare reported FY2026 revenue of Rs. 85,728 lakhs, up 7% from Rs. 80,149 lakhs in FY2025. However, profit after tax declined 19.6% to Rs. 6,568 lakhs (vs Rs. 8,166 lakhs) due to an exceptional charge of Rs. 758 lakhs for new Labour Code compliance. The Board recommended a dividend of Rs. 10 per share (100% payout), same as last year. Key appointments include reappointment of Mr. T T Raghunathan as Executive Chairman for 5 years from November 2026 (current term expires October 2026), and appointment of M/s Geeyes & Co. as Cost Auditor for FY2026-27. Statutory auditors PKF Sridhar & Santhanam gave an unmodified opinion on the financial statements.
The profit decline despite revenue growth reflects one-time regulatory costs and may concern investors expecting margin expansion. The unchanged dividend provides some income support. The leadership continuity with the Chairman's reappointment is neutral-to-positive for governance stability.